Where can I find news about AS?

The latest headlines, third-party analysis, and SEC filings for Amer Sports, Inc. (AS) are listed on this page. Headlines come from across the financial press; filings come directly from SEC EDGAR.

Where are AS's SEC filings?

Amer Sports, Inc. (AS)'s 10-K (annual report), 10-Q (quarterly report), 8-K (current report), and proxy filings are listed in the SEC Filings section on this page with direct links to the official EDGAR copies.

Where are AS's earnings call transcripts?

Full earnings call transcripts for Amer Sports, Inc. (AS), with prepared remarks plus speaker-by-speaker analyst Q&A, live on the Earnings tab alongside the Earnings Reports section that links each quarter's press release and SEC report.

Amer Sports, Inc.

NYSE·Leisure · Consumer Cyclical

$28.24$0.74−2.55%

Market cap$16.43B·Market closed·Oct 23 4:00 PM EDT

News & Analysis

ASO vs. AS: Which Stock Is the Better Value Option?
Investors interested in stocks from the Leisure and Recreation Products sector have probably already heard of Academy Sports and Outdoors, Inc. (ASO) and Amer Sports, Inc. (AS). But which of these two companies is the best option for those looking for undervalued stocks?
zacks.comOct 21, 2026 · 12:41 PM
SKYRIZI® (risankizumab) and RINVOQ® (upadacitinib) Data Highlight Long-Term Clinical and Endoscopic Outcomes Across Inflammatory Bowel Disease (IBD) at UEGW 2026
SKYRIZIÂ (risankizumab) and RINVOQÂ (upadacitinib) Data Highlight Long-Term Clinical and Endoscopic Outcomes Across Inflammatory Bowel Disease (IBD) at UEGW 2
gurufocus.comOct 17, 2026 · 3:00 AM
Amer Sports Chief Strategy Officer Exercises Options to Acquire More than $7 Million Shares. Is This a Signal to Buy AS?
The disposition involved ~117,000 shares for a total value of $3.1 million. Traded shares represented 78% of the equity stake held directly before the filing.
fool.comOct 12, 2026 · 2:10 PM
New SKYRIZI® (risankizumab-rzaa) and RINVOQ® (upadacitinib) Data Demonstrate Disease Control for Patients Living With Inflammatory Bowel Disease
New SKYRIZIÂ (risankizumab-rzaa) and RINVOQÂ (upadacitinib) Data Demonstrate Disease Control for Patients Living With Inflammatory Bowel DiseasePR NewswireNOR
gurufocus.comOct 11, 2026 · 2:00 PM
AbbVie Showcases Leadership in Dermatology Research With New Clinical and Real-World Evidence Across Immune-Mediated Skin Diseases at 2026 EADV Congress
AbbVie Showcases Leadership in Dermatology Research With New Clinical and Real-World Evidence Across Immune-Mediated Skin Diseases at 2026 EADV CongressPR Newsw
gurufocus.comSep 30, 2026 · 2:00 AM
AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Children with Active Polyarticular Juvenile Idiopathic Arthritis
AbbVie Announces European Commission Approval of RINVOQÂ (upadacitinib) for the Treatment of Children with Active Polyarticular Juvenile Idiopathic ArthritisPR
gurufocus.comSep 22, 2026 · 3:00 AM
Financial Comparison: Lakeland Industries (NASDAQ:LAKE) & Amer Sports (NYSE:AS)
Lakeland Industries (NASDAQ: LAKE - Get Free Report) and Amer Sports (NYSE: AS - Get Free Report) are both consumer discretionary companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, valuation, institutional ownership, analyst recommendations, earnings, risk and dividends. Profitability This table compares Lakeland Industries and
defenseworld.netSep 21, 2026 · 2:45 AM
Amer Sports, Inc. (AS) Analyst/Investor Day Transcript
Amer Sports, Inc. (AS) Analyst/Investor Day Transcript
seekingalpha.comSep 18, 2026 · 10:38 AM

SEC Filings

6-K
Oct 16, 2026View on SEC
6-K
Sep 16, 2026View on SEC
SC 13D/A
Aug 24, 2026View on SEC
6-K
Aug 18, 2026View on SEC
6-K
Aug 17, 2026View on SEC
6-K
May 19, 2026View on SEC

Frequently Asked Questions About AS

Where can I find news about AS?: The latest headlines, third-party analysis, and SEC filings for Amer Sports, Inc. (AS) are listed on this page. Headlines come from across the financial press; filings come directly from SEC EDGAR.
Where are AS's SEC filings?: Amer Sports, Inc. (AS)'s 10-K (annual report), 10-Q (quarterly report), 8-K (current report), and proxy filings are listed in the SEC Filings section on this page with direct links to the official EDGAR copies.
Where are AS's earnings call transcripts?: Full earnings call transcripts for Amer Sports, Inc. (AS), with prepared remarks plus speaker-by-speaker analyst Q&A, live on the Earnings tab alongside the Earnings Reports section that links each quarter's press release and SEC report.

Amer Sports, Inc.

Frequently Asked Questions About AS

Amer Sports, Inc.

ASO vs. AS: Which Stock Is the Better Value Option?

SKYRIZI® (risankizumab) and RINVOQ® (upadacitinib) Data Highlight Long-Term Clinical and Endoscopic Outcomes Across Inflammatory Bowel Disease (IBD) at UEGW 2026

Amer Sports Chief Strategy Officer Exercises Options to Acquire More than $7 Million Shares. Is This a Signal to Buy AS?

New SKYRIZI® (risankizumab-rzaa) and RINVOQ® (upadacitinib) Data Demonstrate Disease Control for Patients Living With Inflammatory Bowel Disease

AbbVie Showcases Leadership in Dermatology Research With New Clinical and Real-World Evidence Across Immune-Mediated Skin Diseases at 2026 EADV Congress

AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Children with Active Polyarticular Juvenile Idiopathic Arthritis

Financial Comparison: Lakeland Industries (NASDAQ:LAKE) & Amer Sports (NYSE:AS)

Amer Sports, Inc. (AS) Analyst/Investor Day Transcript

Frequently Asked Questions About AS

ASO vs. AS: Which Stock Is the Better Value Option?

SKYRIZI® (risankizumab) and RINVOQ® (upadacitinib) Data Highlight Long-Term Clinical and Endoscopic Outcomes Across Inflammatory Bowel Disease (IBD) at UEGW 2026

Amer Sports Chief Strategy Officer Exercises Options to Acquire More than $7 Million Shares. Is This a Signal to Buy AS?

New SKYRIZI® (risankizumab-rzaa) and RINVOQ® (upadacitinib) Data Demonstrate Disease Control for Patients Living With Inflammatory Bowel Disease

AbbVie Showcases Leadership in Dermatology Research With New Clinical and Real-World Evidence Across Immune-Mediated Skin Diseases at 2026 EADV Congress

AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Children with Active Polyarticular Juvenile Idiopathic Arthritis

Financial Comparison: Lakeland Industries (NASDAQ:LAKE) & Amer Sports (NYSE:AS)

Amer Sports, Inc. (AS) Analyst/Investor Day Transcript